Kevin Brian Cox - Jul 1, 2024 Form 4 Insider Report for SurgePays, Inc. (SURG)

Role: CEO and Chairman of Board, Director
Signature: /s/ Kevin Brian Cox
Stock symbol: SURG
Transactions as of: Jul 1, 2024
Transactions value $: -$63,826
Form type: 4
Date filed: 7/3/2024, 04:09 PM
Previous filing: Jun 4, 2024
Next filing: Aug 5, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SURG	Restricted Shares (Common Stock)	Award	$0	+83.3K	+1.48%	$0.00	5.71M	Jul 1, 2024	Direct	F1, F2
transaction	SURG	Shares of Common Stock)	Sale	-$63.8K	-20.9K	-0.37%	$3.05	5.69M	Jul 2, 2024	Direct	F3, F4

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	Consists of an RSA grant in the amount of 83,333 set to vest on September 1, 2024.
F2	Includes (i) 83,334 RSAs that vested on July 1, 2024, and (ii) 83,334 RSAs that are set to vest on each of August 1, and September 1, 2024.
F3	The purpose of the sale is solely to cover taxes with vesting of restricted share awards.
F4	Based upon shares sold at a high price of $3.11, a low price of $3.00, and an average of $3.0517. The full breakdown of the prices for all shares sold will be provided at the request of the SEC.